BIMI

transcosmos expands BPO Center Fukuoka Gofukumachi, a center helping DX in Construction

Retrieved on: 
Thursday, March 21, 2024
BIMI, BIM, Construction, DX, Kerosene

TOKYO, March 21, 2024 /PRNewswire-PRWeb/ -- transcosmos inc. hereby announces that the company has expanded BPO Center Fukuoka Gofukumachi, an operations center focused on the construction industry, to accommodate growing business.

Key Points: 
  • TOKYO, March 21, 2024 /PRNewswire-PRWeb/ -- transcosmos inc. hereby announces that the company has expanded BPO Center Fukuoka Gofukumachi, an operations center focused on the construction industry, to accommodate growing business.
  • To be ready for the Revised Labor Standards Act, which is scheduled to take effect in the construction industry in April 2024, the construction industry is accelerating efforts towards process optimization and digital transformation (DX).
  • Building on its expertise in the industry, transcosmos has long been providing various services specifically designed for the construction industry such as Construction Digital BPO, a service for construction related operations, and "to BIM," a comprehensive building information modeling service.
  • Services: Services for the construction industry, Construction Digital BPO, "to BIMI," a comprehensive BIM service
    transcosmos will drive its effort in helping the construction industry achieve DX.

Red Sift Doubles Down on Mission to Help Safeguard Retail and Hospitality Organizations from Brand Abuse

Retrieved on: 
Thursday, February 29, 2024
Technology, Other Retail, Security, Electronic Commerce, Telecommunications, Internet, Lodging, Retail, Online Retail, Travel, Restaurant, POC, Deception, Organization, Associate, DMARC, X86, E-commerce, BIMI, Partnership, Pharmaceutical industry

Red Sift today announced that it has extended its partnership with The Retail & Hospitality Information Sharing and Analysis Center (RH-ISAC), doubling down on its mission to safeguard retail and hospitality organizations.

Key Points: 
  • Red Sift today announced that it has extended its partnership with The Retail & Hospitality Information Sharing and Analysis Center (RH-ISAC), doubling down on its mission to safeguard retail and hospitality organizations.
  • The shift to eCommerce has clear benefits for retail and hospitality businesses in today’s digital-first world, but it also expands their digital footprint.
  • Domain impersonation is one of the primary and most powerful techniques that bad actors leverage to abuse a brand.
  • “Red Sift’s collaboration with the RH-ISAC has significantly advanced our role in improving cybersecurity and protecting the retail and hospitality industry as a whole,” said Rahul Powar, CEO of Red Sift.

BIMI Announces Results of 2023 Annual General Meeting of Stockholders

Retrieved on: 
Wednesday, January 3, 2024
BIMI, Annual

New York, Jan. 03, 2024 (GLOBE NEWSWIRE) -- BIMI Holdings Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), previously known as (BIMI International Medical Inc.) a healthcare products and services provider, today announced the results of the Company’s 2022 Annual General Meeting of Stockholders (the “Annual Meeting”) held on Dec 29, 2023 at 11:00 a.m. at the offices of the Company, 725 5th Ave, New York, NY 10022.

Key Points: 
  • New York, Jan. 03, 2024 (GLOBE NEWSWIRE) -- BIMI Holdings Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), previously known as (BIMI International Medical Inc.) a healthcare products and services provider, today announced the results of the Company’s 2022 Annual General Meeting of Stockholders (the “Annual Meeting”) held on Dec 29, 2023 at 11:00 a.m. at the offices of the Company, 725 5th Ave, New York, NY 10022.
  • At the Annual General Meeting the shareholders voted and approved;
    1.
  • The election of seven directors to serve on the board of directors of the Company, until the next annual meeting of Stockholders and until their respective successors have been duly elected and qualified;
    2.
  • On a non-binding advisory basis, annual  non-binding advisory votes on resolutions approving named executive officer compensation (“Say When on Pay Vote”); and
    6.

BIMI International Medical Inc. Announces Third Quarter 2023 Financial Results

Retrieved on: 
Tuesday, December 19, 2023
BIMI, Sale, Cryptocurrency

NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) --  BIMI International Medical Inc. (the “Company”), a leading medical solutions provider, today announced its financial results for the three months and nine months ended September 30, 2023.

Key Points: 
  • NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) --  BIMI International Medical Inc. (the “Company”), a leading medical solutions provider, today announced its financial results for the three months and nine months ended September 30, 2023.
  • Revenues for the three months ended September 30, 2023 and 2022 were $2,523,193 and $4,932,479, respectively.
  • Revenues for the nine months ended September 30, 2023 and 2022 were $11,278,496 and $10,476,224, respectively.
  • Net loss for the three months ended September 30, 2023 and 2022 was $3,134,072 and $3,099,662, respectively, while net loss for the nine months ended September 30, 2023 and 2022 was$1,146,581 and $12, 214,649, respectively.

BIMI Announces Buyback of Warrants

Retrieved on: 
Tuesday, November 28, 2023
BIMI

NEW YORK, NY, Nov. 28, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, "BIMI"), a healthcare products and services provider, today announced its entry into material definitive agreements with certain of its warrant holders, pursuant to which BIMI agreed to buy back an aggregate of 7,066,913 warrants to purchase shares of common stock of the Company from these warrant holders.

Key Points: 
  • NEW YORK, NY, Nov. 28, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, "BIMI"), a healthcare products and services provider, today announced its entry into material definitive agreements with certain of its warrant holders, pursuant to which BIMI agreed to buy back an aggregate of 7,066,913 warrants to purchase shares of common stock of the Company from these warrant holders.
  • BIMI agreed to pay $0.30 for each share of common stock underlying the warrant, or an aggregate purchase price of $2,120,073.80 to the warrant holders within three (3) business days (for certain sellers), or two (2) months (for certain other sellers), of the signing of the agreements.
  • The warrants will be deemed cancelled upon the receipt by the sellers of the purchase price.

BIMI International Medical Inc. Announces Second Quarter 2023 Financial Results

Retrieved on: 
Monday, November 27, 2023
BIMI, Herbal, Sale

NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the “Company”), a leading medical solutions provider, today announced its financial results for the three months ended June 30, 2023.

Key Points: 
  • NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the “Company”), a leading medical solutions provider, today announced its financial results for the three months ended June 30, 2023.
  • The Company reported a significant increase in gross margin underlining the ongoing success of its business strategy and operational effectiveness.
  • Revenues for the six months ended June 30, 2023 and 2022 were $8,755,303 and $5,543,745, respectively.
  • "We are delighted with the initial success achieved by Phenix Bio Inc.”, said Mr. Tiewei Song, the CEO of BIMI International Medical Inc.

BIMI Announces Subsidiary Phenix Bio Inc.’s New Product Launch

Retrieved on: 
Wednesday, November 8, 2023
BIMI, Phenix, CDFG, Video game

NEW YORK, NY, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Phenix Bio Inc., a wholly owned subsidiary of BIMI International Medical Inc. (NASDAQ: BIMI), a leading global healthcare provider, announces the official launch of its "CUCA 3.0 Product Line through China Duty Free Group's (CDFG) online mini program sales platform.

Key Points: 
  • NEW YORK, NY, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Phenix Bio Inc., a wholly owned subsidiary of BIMI International Medical Inc. (NASDAQ: BIMI), a leading global healthcare provider, announces the official launch of its "CUCA 3.0 Product Line through China Duty Free Group's (CDFG) online mini program sales platform.
  • This significant milestone means China Duty Free’s 26 million members can now purchase Phenix’s products directly from CDFG, solidifying the previous purchase agreement between Phenix and CDFG, which became effective on August 1, 2023.

BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc’s Appointment of Hong Kong, Taiwan, and Macau Exclusive Distributor

Retrieved on: 
Monday, October 30, 2023
ASEAN, BIMI, Herbal, Partnership, Film industry

NEW YORK, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, “BIMI”), a healthcare products and services provider today announced that its subsidiary, Phenix Bio Inc., appointed Hao Mu Pte.

Key Points: 
  • NEW YORK, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, “BIMI”), a healthcare products and services provider today announced that its subsidiary, Phenix Bio Inc., appointed Hao Mu Pte.
  • Ltd., a Singapore company (“Hao Mu”), as its exclusive distributor responsible for the distribution of Phenix’s 17 herbal supplements in Hong Kong, Taiwan and Macau.
  • “We are excited to extend our agreement with Hao Mu,” stated Tiewei Song, CEO of BIMI.
  • Hao Mu was previously appointed as Phenix’s exclusive distributor for the ten-member ASEAN countries.

BIMI International Medical Inc. Announces Subsidiary Phenix Bio Inc’s Appointment of Mainland China Non-Exclusive Distributor

Retrieved on: 
Monday, October 30, 2023
BIMI, Herbal, Partnership, Film industry

NEW YORK, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, “BIMI”), a healthcare products and services provider today announced that its subsidiary, Phenix Bio Inc., appointed Hao Mu Pte.

Key Points: 
  • NEW YORK, NY, Oct. 30, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, “BIMI”), a healthcare products and services provider today announced that its subsidiary, Phenix Bio Inc., appointed Hao Mu Pte.
  • Ltd., a Singapore company (“Hao Mu”), as a distributor responsible for the distribution of Phenix’s 17 herbal supplements in Mainland China.
  • “Expanding our partnership with Hao Mu to Mainland China shows our faith in Hao Mu and its ability to make our products available to wider markets” stated Tiewei Song, CEO of BIMI.
  • This extension of its partnership with Hao Mu evidences BIMI’s commitment to deliver world-class healthcare solutions and services to a broader global audience.

Red Sift Launches Suite of Interoperable Applications to Enable Organizations to Achieve Cyber Resilience

Retrieved on: 
Thursday, November 2, 2023
Software, Technology, Internet, Security, DORA, Intelligence, SPF, BEC, DKIM, PKI, Organization, Risk, DMARC, Workflow, BIMI, IP, Medical device, Risk management

Red Sift today launched a suite of four interoperable applications to enable organizations to proactively address cybersecurity risk before an incident happens.

Key Points: 
  • Red Sift today launched a suite of four interoperable applications to enable organizations to proactively address cybersecurity risk before an incident happens.
  • Organizations today are faced with a new and powerful triple threat that makes them more reactive to security incidents than ever.
  • Security teams lack real-time visibility into the risks and threats facing their businesses, such as lookalike domains that impersonate an organization’s brand and ever-expanding attack surfaces.
  • For more information on the Red Sift applications and the Pulse Platform or to request a demo, please visit https://redsift.com/ .